Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DURECT Corp (NASDAQ:DRRX)

0.8649
Delayed Data
As of 3:59pm ET
 +0.0221 / +2.62%
Today’s Change
0.82
Today|||52-Week Range
2.00
-35.46%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$119.6M

Company Description

DURECT Corp. operates as a biopharmaceutical company. It engages in the development of therapeutics based on its proprietary drug delivery technology platforms. Its brands include ALZET, a osmotic pumps, which is used in laboratory research; and LACTEL, a biodegradable polymers, which is used by pharmaceutical and medical device clients for use as raw materials in their products. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.

Contact Information

DURECT Corp.
10260 Bubb Road
Cupertino California 95014-4166
P:(408) 777-1417
Investor Relations:
(408) 777-4936

Employees

Shareholders

Mutual fund holders9.87%
Other institutional40.48%
Individual stakeholders22.82%

Top Executives

Felix TheeuwesChairman & Chief Scientific Officer
James E. BrownPresident, Chief Executive Officer & Director
Judy JoiceSenior VP-Operations & Corporate Quality Assurance
Matt HoganCFO, Secretary & Principal Accounting Officer
Steve HelmerChief Patent Counsel & Vice President